))
Red Beard Ventures Summit 2024 | Trends & innovations in Biotech
Manage episode 402635977 series 3532365
Contenido proporcionado por Red Beard Ventures. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Red Beard Ventures o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Drew Austin welcomes two experts in the Biotech field to discuss discoveries in psychedelics, cancer treatment, and more. Peter Weijmarshausen, CEO/Co-founder of Humane Genomics and Sam Clark, Founder/CEO of Terran Biosciences highlight how biotech is offering amazing opportunities for investments in scientific innovation.
Participating Panelists:
- Drew Austin, Managing Partner, Red Beard Ventures
- Peter Weijmarshausen, CEO/Co-founder, Humane Genomics
- Sam Clark, Founder/CEO, Terran Biosciences
Main Topics:
- Terran Bioscience developing prescription psychedelic therapies for mental health.
- Human Genomics' revolutionary approach to using synthetic biology to target and eliminate cancer cells.
- The challenges of scientific innovation.
- Finding opportunities for capital deployment in biotech
- Developing affordable treatments for all - making healthcare accessible
Red Beard Ventures: https://redbeard.ventures/
Angel List Syndicate: https://venture.angellist.com/red-beard-ventures-drew-austin/syndicate?utm_campaign=syndicate_direct_link
Red Beard Radio is Sponsored by Alto. Alto makes it easy for individuals to invest in alternative assets with their retirement funds through a self-directed IRA. Access private deals on Alto Marketplace, their new platform for accredited investors: https://www.altoira.com/marketplace
X: @RedBeardVC
Watch the show on YouTube: https://www.youtube.com/channel/UCY-DGmpg2v2rEcXEjn8hJlw
44 episodios
Compartir
